4D Molecular Therapeutics, Inc. — DEFA14A Filings
5 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by 4D Molecular Therapeutics, Inc. (FDMT), sorted by most recent first. Each row links to the full filing on EdgarLookup. 4D Molecular Therapeutics, Inc. has filed 5 DEFA14A documents with the SEC since 2015. To view all SEC filings by 4D Molecular Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001140361-25-016320 | Apr 29, 2025 | — |
| DEFA14A | DEFA14A | 0001140361-24-019094 | Apr 10, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-23-098528 | Apr 12, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-22-104271 | Apr 13, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-21-107770 | Apr 6, 2021 | — |